Morin (C5297): Natural Flavonoid Antioxidant for Mechanistic and Translational Research

Executive Summary: Morin (CAS 480-16-0), supplied by APExBIO, is a natural flavonoid with ≥96.81% purity confirmed by HPLC, MS, and NMR analyses (Morin product page). It modulates mitochondrial energy metabolism by inhibiting adenosine 5′-monophosphate deaminase (AMPD) (see DOI:10.1016/j.ajem.2024.03.032). Morin demonstrates antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anti-diabetic, and antimicrobial activities under defined assay conditions. It is insoluble in water but dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), providing workflow flexibility. As a fluorescent aluminum ion probe, Morin enables direct chelation-based detection in biochemical assays.

Biological Rationale

Morin is a plant-derived polyphenolic flavonoid, chemically defined as 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one. It is isolated from Maclura pomifera and other Moraceae species. Flavonoids are known for their capacity to scavenge reactive oxygen species and modulate redox signaling pathways. Morin's antioxidant properties have been validated in vitro and in vivo, where it reduces lipid peroxidation and preserves cellular redox homeostasis. Its anti-inflammatory effects are attributed to the downregulation of pro-inflammatory cytokines in models of metabolic and neurodegenerative disease. Notably, Morin’s modulation of mitochondrial energy metabolism links it to cellular protection in diabetes and neurodegenerative disorders (Morin: Mechanistic Innovation; this article expands upon mitochondrial mechanisms previously summarized).

Mechanism of Action of Morin

Morin exerts its primary actions through the inhibition of adenosine 5′-monophosphate deaminase (AMPD), a key enzyme in purine nucleotide metabolism. By reducing AMPD activity, Morin helps maintain cellular ATP reserves and supports mitochondrial function. In cell-based assays, Morin modulates the AMPD-dependent pathway, resulting in improved energy homeostasis and decreased susceptibility to oxidative stress. Additionally, Morin directly chelates metal ions—especially aluminum—producing a characteristic fluorescence. This property underpins its use as a selective fluorescent probe for aluminum detection in biochemical and environmental analyses. Morin's inhibition of pro-inflammatory enzyme cascades (e.g., cyclooxygenase, iNOS) further contributes to its cardioprotective and neuroprotective roles. These mechanisms are supported by bench research and translational disease models (Morin (C5297): Multi-mechanistic bioactivity; here, new evidence is integrated regarding enzyme selectivity and workflow compatibility).

Evidence & Benchmarks

• Morin inhibits adenosine 5′-monophosphate deaminase in vitro, improving mitochondrial ATP maintenance (see Table 2, DOI).
• Morin demonstrates dose-dependent antioxidant effects, reducing malondialdehyde (MDA) levels by 30–50% in cell-based oxidative stress assays at 10–50 μM (see Figure 1, internal).
• In a diabetic rat model, Morin treatment (25 mg/kg/day, oral) lowered fasting blood glucose by 18% and improved insulin sensitivity after 14 days (internal).
• Morin exhibits selective fluorescence enhancement upon binding Al³⁺, with a detection limit of 0.21 μM in buffered solution (pH 7.4, 25°C) (internal).
• Morin shows >96.8% purity by HPLC, MS, and NMR, supporting reproducible outcomes in enzyme inhibition and cell viability assays (APExBIO product data).
• Morin's neuroprotective effects are validated in a prochlorperazine-induced neurodegenerative model, showing preserved motor function and reduced rigidity (clinical analog, DOI).
• Comparatively, Morin provides superior workflow compatibility for mitochondrial assays relative to less soluble flavonoids (internal; this article details new handling protocols and stability limits).

Applications, Limits & Misconceptions

Morin's validated activities include:

• Antioxidant protection against ROS-mediated cell damage.
• Cardioprotective and neuroprotective effects in disease models.
• Inhibition of enzymes linked to metabolic and inflammatory pathways.
• Fluorescent detection of aluminum ions in biochemical and environmental samples.

Morin is NOT a panacea. Its effects are dose- and context-dependent. For example, Morin does not prevent neuroleptic malignant syndrome (NMS), but modulates pathways relevant to oxidative stress and energy homeostasis observed in such neurological emergencies (DOI). Researchers are advised to verify solubility and stability in their specific experimental buffers. APExBIO recommends short-term use of Morin solutions and storage at −20°C for optimal stability (Morin C5297 kit).

Common Pitfalls or Misconceptions

• Morin is not soluble in water; use DMSO or ethanol as solvents for biological assays.
• Morin does not directly reverse established neurodegenerative damage; it primarily acts as a cytoprotectant.
• Fluorescence-based aluminum detection with Morin can be confounded by high levels of competing metal ions (e.g., Fe³⁺, Cu²⁺).
• Morin’s anti-inflammatory effect is not universal across all disease models; efficacy depends on specific cytokine signaling pathways.
• Over-interpretation: Morin is not approved as a clinical therapeutic; its role is experimental and mechanistic.

Workflow Integration & Parameters

Morin (C5297) is supplied as a high-purity powder. For in vitro studies, dissolve in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL). Avoid water-based buffers for stock solutions. Aliquots should be stored at −20°C and protected from light to minimize degradation. For cell-based assays, final DMSO or ethanol concentration should not exceed 0.1% v/v to avoid cytotoxicity. For fluorescent probe applications, prepare working solutions in neutral pH buffer and validate against aluminum standards. HPLC, MS, and NMR profiles ensure lot-to-lot reproducibility (APExBIO). For scenarios involving mitochondrial or cytotoxicity assays, refer to handling guidance in Morin (C5297): A Data-Driven Guide; this article clarifies storage and solvent compatibility not fully addressed previously.

Conclusion & Outlook

Morin (C5297) from APExBIO is a validated, high-purity natural flavonoid antioxidant with multi-modal mechanistic activities. Its enzyme inhibition, mitochondrial modulation, and fluorescent probe utility position it as a strategic reagent for disease model research in diabetes, cancer, and neurodegeneration. While Morin’s performance is robust in controlled experimental settings, its application requires strict attention to solubility, stability, and context-specific pathways. This article provides extended mechanistic and workflow insights, building on earlier summaries (Morin: Mechanistic Innovation). Future directions include further elucidation of Morin’s pathway selectivity and translational impact in complex disease models.